Apis India Limited Announces Resignation of National Sales Head Mr. Sharad Vatss
Apis India Limited announced the resignation of National Sales Head Mr. Sharad Vatss, effective April 15, 2026, due to personal and professional reasons. The company filed the mandatory disclosure with BSE on April 16, 2026, under SEBI LODR Regulation 30, ensuring full regulatory compliance and transparency in corporate governance.

*this image is generated using AI for illustrative purposes only.
Apis India Limited has announced the resignation of its National Sales Head, Mr. Sharad Vatss, through a regulatory filing with the BSE on April 16, 2026. The resignation became effective from the closure of business hours on April 15, 2026.
Regulatory Compliance and Filing Details
The company submitted the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with Schedule III provisions. The filing was signed by Managing Director Amit Anand and includes reference number AIL/CS/2026-27/466.
Resignation Details
According to the mandatory disclosure requirements, the company provided comprehensive information about the leadership change:
| Parameter | Details |
|---|---|
| Position | National Sales Head |
| Employee Name | Mr. Sharad Vatss |
| Effective Date | April 15, 2026 (closure of business hours) |
| Reason | Personal and professional reasons |
| Nature of Change | Resignation |
Compliance Framework
The disclosure follows SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, ensuring full regulatory compliance. The company has also uploaded the intimation on its official website at www.apisindia.com for public access.
Company Information
Apis India Limited operates from its registered office at East Patel Nagar, New Delhi, with manufacturing works located in Roorkee, Uttarakhand. The pharmaceutical company maintains transparency in corporate governance through timely regulatory filings and stakeholder communications.
Historical Stock Returns for Apis
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.70% | -2.23% | +11.36% | +75.86% | +414.08% | +8,151.95% |
How will Apis India's sales performance be affected during the transition period before appointing a new National Sales Head?
What strategic changes might the new National Sales Head implement to drive growth in India's competitive pharmaceutical market?
Could this leadership change signal broader organizational restructuring at Apis India in the coming quarters?


































